| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |